156 related articles for article (PubMed ID: 30740953)
1. How to evaluate the adequacy of staging for nodal-negative epithelial ovarian cancer? Use of nodal staging score.
Xu Y; Li H; Tong X; Pang Y; Tong X; Li L; Cheng L
J Gynecol Oncol; 2019 Mar; 30(2):e21. PubMed ID: 30740953
[TBL] [Abstract][Full Text] [Related]
2. Nodal staging score: a tool to assess adequate staging of node-negative colon cancer.
Gönen M; Schrag D; Weiser MR
J Clin Oncol; 2009 Dec; 27(36):6166-71. PubMed ID: 19901106
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the adequacy of nodal status in node-negative gallbladder cancer with T1b-T2 stages: use of nodal staging score.
Huang XT; Huang CS; Li JH; Chen W; Gan TT; Wang XY; Liang LJ; Yin XY
HPB (Oxford); 2021 May; 23(5):795-801. PubMed ID: 33051141
[TBL] [Abstract][Full Text] [Related]
4. Nodal staging score and adequacy of nodal staging.
Chen HM; Feng G
Onco Targets Ther; 2019; 12():449-455. PubMed ID: 30662271
[TBL] [Abstract][Full Text] [Related]
5. External validation of the pathological nodal staging score in upper tract urothelial carcinoma: A population-based study.
Xylinas E; Kluth L; Rieken M; Rouprêt M; Al Hussein Al Awamlh B; Clozel T; Sun M; Karakiewicz PI; Gonen M; Shariat SF
Urol Oncol; 2017 Jan; 35(1):33.e21-33.e26. PubMed ID: 27816402
[TBL] [Abstract][Full Text] [Related]
6. Use of Nodal Staging Score in Evaluating the Accuracy of Pathologic Nodal Status in Node-Negative Ampullary Carcinoma.
Huang XT; Huang CS; Li JH; Xu QC; Yin XY
J Gastrointest Surg; 2021 Apr; 25(4):1001-1009. PubMed ID: 32253644
[TBL] [Abstract][Full Text] [Related]
7. Development and external validation of a pathological nodal staging score for patients with clear cell renal cell carcinoma.
Rieken M; Boorjian SA; Kluth LA; Capitanio U; Briganti A; Thompson RH; Leibovich BC; Krabbe LM; Margulis V; Raman JD; Regelman M; Karakiewicz PI; Rouprêt M; Abufaraj M; Foerster B; Gönen M; Shariat SF
World J Urol; 2019 Aug; 37(8):1631-1637. PubMed ID: 30406477
[TBL] [Abstract][Full Text] [Related]
8. Pathologic node-negative lung cancer: Adequacy of lymph node yield and a tool to assess the risk of occult nodal disease.
Tan KS; Hsu M; Adusumilli PS
Lung Cancer; 2022 Dec; 174():60-66. PubMed ID: 36334358
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging.
Powless CA; Aletti GD; Bakkum-Gamez JN; Cliby WA
Gynecol Oncol; 2011 Sep; 122(3):536-40. PubMed ID: 21636114
[TBL] [Abstract][Full Text] [Related]
10. Incidence of Lymph Node Metastases in Apparent Early-Stage Low-Grade Epithelial Ovarian Cancer: A Comprehensive Review.
Lago V; Minig L; Fotopoulou C
Int J Gynecol Cancer; 2016 Oct; 26(8):1407-14. PubMed ID: 27465900
[TBL] [Abstract][Full Text] [Related]
11. Nodal staging score: a tool for survival prediction of node-negative bladder cancer.
Ku JH; Kim HH; Kwak C
Urol Oncol; 2013 Nov; 31(8):1731-6. PubMed ID: 23141779
[TBL] [Abstract][Full Text] [Related]
12. Pathologic nodal staging scores in patients treated with radical prostatectomy: a postoperative decision tool.
Kluth LA; Abdollah F; Xylinas E; Rieken M; Fajkovic H; Sun M; Karakiewicz PI; Seitz C; Schramek P; Herman MP; Becker A; Loidl W; Pummer K; Nonis A; Lee RK; Lotan Y; Scherr DS; Seiler D; Chun FK; Graefen M; Tewari A; Gönen M; Montorsi F; Shariat SF; Briganti A
Eur Urol; 2014 Sep; 66(3):439-46. PubMed ID: 23850255
[TBL] [Abstract][Full Text] [Related]
13. Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomy.
Shariat SF; Rink M; Ehdaie B; Xylinas E; Babjuk M; Merseburger AS; Svatek RS; Cha EK; Tagawa ST; Fajkovic H; Novara G; Karakiewicz PI; Trinh QD; Daneshmand S; Lotan Y; Kassouf W; Fritsche HM; Chun FK; Sonpavde G; Joual A; Scherr DS; Gonen M
Eur Urol; 2013 Feb; 63(2):371-8. PubMed ID: 22727174
[TBL] [Abstract][Full Text] [Related]
14. A novel nomogram based on LODDS to predict the prognosis of epithelial ovarian cancer.
Xu XL; Cheng H; Tang MS; Zhang HL; Wu RY; Yu Y; Li X; Wang XM; Mai J; Yang CL; Jiao L; Li ZL; Zhong ZM; Deng R; Li JD; Zhu XF
Oncotarget; 2017 Jan; 8(5):8120-8130. PubMed ID: 28042955
[TBL] [Abstract][Full Text] [Related]
15. How many lymph nodes should be dissected in esophagectomy with or without neoadjuvant therapy to get accurate staging?
Zhan C; Shi Y; Jiang W; Sun F; Li M; Lu T; Yin J; Ma K; Yang X; Wang Q
Dis Esophagus; 2020 Jan; 33(1):. PubMed ID: 30997490
[TBL] [Abstract][Full Text] [Related]
16. Assessing the adequacy of lymph node yield for different tumor stages of colon cancer by nodal staging scores.
Wu Z; Qin G; Zhao N; Jia H; Zheng X
BMC Cancer; 2017 Jul; 17(1):498. PubMed ID: 28743236
[TBL] [Abstract][Full Text] [Related]
17. The optimal number of examined lymph nodes for accurate staging of intrahepatic cholangiocarcinoma: A multi-institutional analysis using the nodal staging score model.
Zhang R; Zhang J; Chen C; Qiu Y; Wu H; Song T; He Y; Li J; Zhang D; Geng Z; Tang Z
Eur J Surg Oncol; 2023 Aug; 49(8):1429-1435. PubMed ID: 37005204
[TBL] [Abstract][Full Text] [Related]
18. Determining the optimal number of examined lymph nodes for accurate staging of pancreatic cancer: An analysis using the nodal staging score model.
Hua J; Zhang B; Xu J; Liu J; Ni Q; He J; Zheng L; Yu X; Shi S
Eur J Surg Oncol; 2019 Jun; 45(6):1069-1076. PubMed ID: 30685327
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of nodal staging score in pN0 patients with esophageal squamous cell carcinoma: A population study from the SEER database and a single-institution cohort.
Wang H; Yang Y; Zhu K; Zhu N; Gong L; Zhang H; Ma M; Ren P; Qiao Y; Liu X; Tang P; Yu Z
Thorac Cancer; 2022 Dec; 13(23):3257-3267. PubMed ID: 36221304
[TBL] [Abstract][Full Text] [Related]
20. How Many Lymph Nodes Are Enough? Assessing the Adequacy of Lymph Node Yield for Papillary Thyroid Cancer.
Robinson TJ; Thomas S; Dinan MA; Roman S; Sosa JA; Hyslop T
J Clin Oncol; 2016 Oct; 34(28):3434-9. PubMed ID: 27528716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
